AURA Aura Biosciences, Inc.
Nasdaq · SEC CIK 1501796 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $40.06M 14 sales by 7 insiders
- Filings on record
- 112 since 2021-10-29, latest 2026-09-01 17:28
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Matrix Capital Management Company, LP | 10% | — | $39.04M |
| de los Pinos Elisabet | See Remarks, Dir | — | $380.8K |
| Hopkins Janet Jill | Chief Medical Off | — | $196.0K |
| Plavsic Mark | CTO | — | $157.5K |
| Kilroy Conor | See Remarks | — | $143.4K |
| Gibney Anthony S | See Remarks | — | $82.3K |
| Elazzouzi Amy | SVP, Fin, PAO | — | $56.6K |
| Kratz Erica | Chief Reg, Quality Off | — | — |
| Abu-Absi Susan | COO | — | — |
| Bitetti Teresa Marie | Dir | — | — |
Transactions 111
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2021-11-04 | 2021-11-02 | AURA | Medicxi Growth I LP | 10% | P - Purchase | $14.00 | +710.0K | 70.5K | New | +$9.94M |
| DMI | 2021-11-04 | 2021-11-02 | AURA | Medicxi Growth I LP | 10% | C - Cnv Deriv | — | +2.33M | 54.1K | New | — |
| DI | 2021-11-04 | 2021-11-02 | AURA | GOEL DAVID E. | 10% | C - Cnv Deriv | — | +2.33M | 2.33M | New | — |
| DI | 2021-11-04 | 2021-11-02 | AURA | GOEL DAVID E. | 10% | P - Purchase | $14.00 | +1.78M | 4.11M | +77% | +$24.99M |
| DI | 2021-11-02 | 2021-11-02 | AURA | Johnson David Michael | Dir | C - Cnv Deriv | $0.00 | +139.7K | 139.7K | New | $0 |
| DI | 2021-11-02 | 2021-11-02 | AURA | de los Pinos Elisabet | See Remarks, Dir | C - Cnv Deriv | $0.00 | +4,552 | 131.4K | +4% | $0 |
| D | 2021-10-29 | 2021-10-28 | AURA | Primiano Christopher Brett | Chief Business Off | A - Grant | $0.00 | +8,750 | 8,750 | New | $0 |
| D | 2021-10-29 | 2021-10-28 | AURA | Rich Cadmus | See Remarks | A - Grant | $0.00 | +26.2K | 26.2K | New | $0 |
| D | 2021-10-29 | 2021-10-28 | AURA | De Rosch Mark | COO | A - Grant | $0.00 | +17.5K | 17.5K | New | $0 |
| D | 2021-10-29 | 2021-10-28 | AURA | Feder Julie B | CFO | A - Grant | $0.00 | +26.2K | 26.2K | New | $0 |
| D | 2021-10-29 | 2021-10-28 | AURA | de los Pinos Elisabet | See Remarks, Dir | A - Grant | $0.00 | +74.4K | 74.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations